159 related articles for article (PubMed ID: 22296379)
1. XRCC1 polymorphisms and risk of nasopharyngeal carcinoma: a meta-analysis.
Huang GL; Guo HQ; Yu CY; Liu XY; Li BB; Wu JJ; He ZW
Asian Pac J Cancer Prev; 2011; 12(9):2329-33. PubMed ID: 22296379
[TBL] [Abstract][Full Text] [Related]
2. Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population.
Li Q; Wang JM; Peng Y; Zhang SH; Ren T; Luo H; Cheng Y; Wang D
Asian Pac J Cancer Prev; 2013; 14(9):5145-51. PubMed ID: 24175791
[TBL] [Abstract][Full Text] [Related]
3. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population.
Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS
Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population.
Cao Y; Miao XP; Huang MY; Deng L; Hu LF; Ernberg I; Zeng YX; Lin DX; Shao JY
BMC Cancer; 2006 Jun; 6():167. PubMed ID: 16796765
[TBL] [Abstract][Full Text] [Related]
5. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
6. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
Li J; Li Z; Feng L; Guo W; Zhang S
Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
[TBL] [Abstract][Full Text] [Related]
8. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
[TBL] [Abstract][Full Text] [Related]
9. XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies.
Dai L; Wang K; Zhang J; Lv Q; Wu X; Wang Y
Int J Cancer; 2009 Sep; 125(5):1102-9. PubMed ID: 19444915
[TBL] [Abstract][Full Text] [Related]
10. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
Wang YD; Zhai WL; Wang HY; Xia XQ
Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
[TBL] [Abstract][Full Text] [Related]
11. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
Li Y; Liu F; Tan SQ; Wang Y; Li SW
PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
[TBL] [Abstract][Full Text] [Related]
12. Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: An update meta-analysis.
Lin J; Ye Q; Wang Y; Wang Y; Zeng Y
Medicine (Baltimore); 2018 Aug; 97(32):e11852. PubMed ID: 30095663
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study.
Saadat M; Kohan L; Omidvari S
Breast Cancer Res Treat; 2008 Oct; 111(3):549-53. PubMed ID: 17987379
[TBL] [Abstract][Full Text] [Related]
14. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
Wei B; Zhou Y; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):225-31. PubMed ID: 21647176
[TBL] [Abstract][Full Text] [Related]
15. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Hu Z; Hu X; Long J; Su L; Wei B
Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan.
Yin G; Morita M; Ohnaka K; Toyomura K; Hamajima N; Mizoue T; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Yasunami Y; Maekawa T; Takenaka K; Ichimiya H; Terasaka R
J Epidemiol; 2012; 22(1):64-71. PubMed ID: 22186158
[TBL] [Abstract][Full Text] [Related]
17. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X
Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084
[TBL] [Abstract][Full Text] [Related]
19. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
Qi Y; Cui L; Song Y; Li N
Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
[TBL] [Abstract][Full Text] [Related]
20. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
Zhao DY; Cheng L; Yu J; Shen H
Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
